77 research outputs found

    Hansenula polymorpha: An attractive model organism for molecular studies of peroxisome biogenesis and function

    Get PDF
    In wild-type Hansenula polymorpha the proliferation of peroxisomes is induced by various unconventional carbon- and nitrogen sources. Highest induction levels, up to 80% of the cytoplasmic volume, are observed in cells grown in methanol-limited chemostat cultures. Based on our accumulated experience, we are now able to precisely adjust both the level of peroxisome induction as well as their protein composition by specific adaptations in growth conditions. During the last few years a series of peroxisome-deficient (per) mutants of H. polymorpha have been isolated and characterized. Phenotypically these mutants are characterized by the fact that they are not able to grow on methanol. Three mutant phenotypes were defined on the basis of morphological criteria, namely: (a) mutants completely lacking peroxisomes (Per-; 13 complementation groups); (b) mutants containing few small peroxisomes which are partly impaired in the peroxisomal import of matrix proteins (Pim-; five complementation groups); and (c) mutants with aberrations in the peroxisomal substructure (Pss-; two complementation groups). In addition, several conditional Per-, Pim- and Pss- mutants have been obtained. In all cases the mutant phenotype was shown to be caused by a recessive mutation in one gene. However, we observed that different mutations in one gene may cause different morphological mutant phenotypes. A detailed genetic analysis revealed that several PER genes, essential for peroxisome biogenesis, are tightly linked and organized in a hierarchical fashion. The use of both constitual and conditional per mutants in current and future studies of the molecular mechanisms controlling peroxisome biogenesis and function is discussed.

    Hansenula polymorpha Swi1p and Snf2p are essential for methanol utilisation

    Get PDF
    We have cloned the Hansenula polymorpha SWI1 and SNF2 genes by functional complementation of mutants that are defective in methanol utilisation. These genes encode proteins similar to Saccharomyces cerevisiae Swi1p and Snf2p, which are subunits of the SWI/SNF complex. This complex belongs to the family of nucleosome-remodeling complexes that play a role in transcriptional control of gene expression. Analysis of the phenotypes of constructed H. polymorpha SWI1 and SNF2 disruption strains indicated that these genes are not necessary for growth of cells on glucose, sucrose, or various organic nitrogen sources which involve the activity of peroxisomal oxidases. Both disruption strains showed a moderate growth defect on glycerol and ethanol, but were fully blocked in methanol utilisation. In methanol-induced cells of both disruption strains, two peroxisomal enzymes involved in methanol metabolism, alcohol oxidase and dihydroxyacetone synthase, were hardly detectable, whereas in wild-type cells these proteins were present at very high levels. We show that the reduction in alcohol oxidase protein levels in H. polymorpha SWI1 and SNF2 disruption strains is due to strongly reduced expression of the alcohol oxidase gene. The level of Pex5p, the receptor involved in import of alcohol oxidase and dihydroxyacetone synthase into peroxisomes, was also reduced in both disruption strains compared to that in wild-type cells.

    ĐœĐ”Ń‚Đ°Đ±ĐŸĐ»ĐžŃ‡Đ”ŃĐșĐžĐč ŃĐžĐœĐŽŃ€ĐŸĐŒ Đž ĐżŃ€ĐžŃĐŸĐ”ĐŽĐžĐœĐ”ĐœĐžĐ” баĐșŃ‚Đ”Ń€ĐžĐ°Đ»ŃŒĐœĐŸĐč ĐžĐœŃ„Đ”Đșцоо ĐșĐ°Đș фаĐșŃ‚ĐŸŃ€Ń‹ росĐșĐ° Ń„Đ°Ń‚Đ°Đ»ŃŒĐœĐŸĐłĐŸ ĐžŃŃ…ĐŸĐŽĐ° про грОппД А / H1N1, ĐŸŃĐ»ĐŸĐ¶ĐœĐ”ĐœĐœĐŸĐŒ ĐżĐœĐ”ĐČĐŒĐŸĐœĐžĐ”Đč

    Get PDF
    Metabolic syndrome and bacterial infection as risk factors of death in influenza А / H1N1 complicated by pneumonia.ĐœĐ”Ń‚Đ°Đ±ĐŸĐ»ĐžŃ‡Đ”ŃĐșĐžĐč ŃĐžĐœĐŽŃ€ĐŸĐŒ Đž ĐżŃ€ĐžŃĐŸĐ”ĐŽĐžĐœĐ”ĐœĐžĐ” баĐșŃ‚Đ”Ń€ĐžĐ°Đ»ŃŒĐœĐŸĐč ĐžĐœŃ„Đ”Đșцоо ĐșĐ°Đș фаĐșŃ‚ĐŸŃ€Ń‹ росĐșĐ° Ń„Đ°Ń‚Đ°Đ»ŃŒĐœĐŸĐłĐŸ ĐžŃŃ…ĐŸĐŽĐ° про грОппД А / H1N1, ĐŸŃĐ»ĐŸĐ¶ĐœĐ”ĐœĐœĐŸĐŒ ĐżĐœĐ”ĐČĐŒĐŸĐœĐžĐ”Đč

    Đ›Đ˜ĐŸĐžĐŸĐžĐ›Đ˜ĐĄĐĐ„ĐĐ Đ˜Đ”-ĐĄĐ’ĐŻĐ—Đ«Đ’ĐĐźĐ©Đ˜Đ™ БЕЛОК, НЕОПбЕРИН И Đ˜ĐĐąĐ•Đ Đ€Đ•Đ ĐžĐ-Г КАК ПОКАЗАбЕЛИ АКбИВНОСбИ ВОСПАЛЕНИЯ ĐŁ Đ‘ĐžĐ›ĐŹĐĐ«Đ„ ĐžĐĄĐąĐ Đ«Đœ БРУЩЕЛЛЁЗОМ

    Get PDF
    Brucellosis is characterized by nonspecific clinical manifestations, the possibility of subclinical flow, the development of relapses and chronic course. Currently, there are no laboratory criteria to assess the activity of inflammation in brucellosis, the effectiveness of the therapy, predict the outcome of the disease and the risks of recurrence. Available in clinical practice, laboratory tests to assess inflammation, in particular, erythrocyte sedimentation rate, C-reactive protein, leukocyte level, with brucellosis infection are almost not informative. An important role in the development of the cellular immune response against brucella is played by interferon-Îł, lipopolysaccharide-binding protein and neopterin. The aim of the study was to determine the level of lipopolysaccharide-binding protein, neopterin and interferon-Îł, in the serum of patients with acute form of brucellosis before and after antibacterial treatment. When studying the blood of patients with acute brucellosis before and after therapy, the indices of neopterin, lipopolysaccharide-binding protein and interferon-Îł were significantly higher than normal values. The obtained results testify to the persisting active inflammation and the formation of a chronic brucellosis. Determination of the level of lipopolysaccharide-binding protein, neopterin and interferon-Îł in the blood of patients with brucellosis can be used as markers of inflammation and in monitoring the effectiveness of antibacterial therapy.ĐŠĐ”Đ»ŃŒ: ĐŸĐżŃ€Đ”ĐŽĐ”Đ»Đ”ĐœĐžĐ” ŃƒŃ€ĐŸĐČĐœŃ ЛПС-бДлĐșĐ°, ĐœĐ”ĐŸĐżŃ‚Đ”Ń€ĐžĐœĐ° Đž Đ˜Đ€Đ- Îł ĐČ ŃŃ‹ĐČĐŸŃ€ĐŸŃ‚ĐșĐ” ĐșŃ€ĐŸĐČĐž Đ±ĐŸĐ»ŃŒĐœŃ‹Ń… с ĐŸŃŃ‚Ń€ĐŸĐč Ń„ĐŸŃ€ĐŒĐŸĐč Đ±Ń€ŃƒŃ†Đ”Đ»Đ»Đ”Đ·Đ° ĐŽĐŸ Đž ĐżĐŸŃĐ»Đ” Đ»Đ”Ń‡Đ”ĐœĐžŃ Đ°ĐœŃ‚ĐžĐ±Đ°ĐșŃ‚Đ”Ń€ĐžĐ°Đ»ŃŒĐœŃ‹ĐŒĐž ĐżŃ€Đ”ĐżĐ°Ń€Đ°Ń‚Đ°ĐŒĐž. ĐœĐ°Ń‚Đ”Ń€ĐžĐ°Đ»Ń‹ Đž ĐŒĐ”Ń‚ĐŸĐŽŃ‹: ĐČ ĐžŃŃĐ»Đ”ĐŽĐŸĐČĐ°ĐœĐžĐ” ĐČĐșĐ»ŃŽŃ‡Đ”ĐœŃ‹ 65 Đ±ĐŸĐ»ŃŒĐœŃ‹Ń… ĐŸŃŃ‚Ń€Ń‹ĐŒ Đ±Ń€ŃƒŃ†Đ”Đ»Đ»Đ”Đ·ĐŸĐŒ. Đ”Đ»Ń ĐŸĐżŃ€Đ”ĐŽĐ”Đ»Đ”ĐœĐžŃ ŃƒŃ€ĐŸĐČĐœŃ ЛПС-бДлĐșĐ° ĐČ ŃŃ‹ĐČĐŸŃ€ĐŸŃ‚ĐșĐ” ĐșŃ€ĐŸĐČĐž ĐžŃĐżĐŸĐ»ŃŒĐ·ĐŸĐČалО Ń‚Đ”ŃŃ‚ŃĐžŃŃ‚Đ”ĐŒŃ‹ «Hycultbiotech, Netherlands», ELISA. ĐŁŃ€ĐŸĐČĐ”ĐœŃŒ ĐœĐ”ĐŸĐżŃ‚Đ”Ń€ĐžĐœĐ° ĐČ ŃŃ‹ĐČĐŸŃ€ĐŸŃ‚ĐșĐ” ĐșŃ€ĐŸĐČĐž ĐŸĐżŃ€Đ”ĐŽĐ”Đ»ŃĐ»Đž с ĐżĐŸĐŒĐŸŃ‰ŃŒŃŽ тДст-ŃĐžŃŃ‚Đ”ĐŒ Neopterin ELISA «IBL, Hamburg». ĐžĐżŃ€Đ”ĐŽĐ”Đ»Đ”ĐœĐžĐ” ŃƒŃ€ĐŸĐČĐœŃ Đ˜Đ€Đ- Îł ĐČ ŃŃ‹ĐČĐŸŃ€ĐŸŃ‚ĐșĐ” ĐșŃ€ĐŸĐČĐž ĐżŃ€ĐŸĐČĐŸĐŽĐžĐ»Đž Ń‚Đ”ŃŃ‚ŃĐžŃŃ‚Đ”ĐŒĐ°ĐŒĐž Đ’Đ”ĐșŃ‚ĐŸŃ€ БДст А-8752 ĐłĐ°ĐŒĐŒĐ°-Đ˜ĐœŃ‚Đ”Ń€Ń„Đ”Ń€ĐŸĐœĐ˜Đ€Đ-БЕСб ĐżŃ€ĐŸĐžĐ·ĐČĐŸĐŽŃŃ‚ĐČĐ° «ВДĐșŃ‚ĐŸŃ€-БЕХй», Đ ĐŸŃŃĐžŃ. Группу сраĐČĐœĐ”ĐœĐžŃ ŃĐŸŃŃ‚Đ°ĐČОлО 32 Đ·ĐŽĐŸŃ€ĐŸĐČых ĐŽĐŸĐœĐŸŃ€Đ°, ŃĐŸĐżĐŸŃŃ‚Đ°ĐČĐžĐŒŃ‹Đ” ĐżĐŸ ĐżĐŸĐ»Ńƒ Đž ĐČĐŸĐ·Ń€Đ°ŃŃ‚Ńƒ с Đ±ĐŸĐ»ŃŒĐœŃ‹ĐŒĐž Đ±Ń€ŃƒŃ†Đ”Đ»Đ»Đ”Đ·ĐŸĐŒ, ĐœĐ” Đ±ĐŸĐ»Đ”ĐČшОД ŃŃ‚ĐŸĐč ĐžĐœŃ„Đ”ĐșцОДĐč, ĐœĐ” ĐČĐ°ĐșŃ†ĐžĐœĐžŃ€ĐŸĐČĐ°ĐœĐœŃ‹Đ” ĐżŃ€ĐŸŃ‚ĐžĐČ ŃŃ‚ĐŸĐč ĐžĐœŃ„Đ”Đșцоо. ХпДцОфОчДсĐșОД Đ»Đ°Đ±ĐŸŃ€Đ°Ń‚ĐŸŃ€ĐœŃ‹Đ” ĐžŃŃĐ»Đ”ĐŽĐŸĐČĐ°ĐœĐžŃ ĐșŃ€ĐŸĐČĐž, ĐŸĐżŃ€Đ”ĐŽĐ”Đ»Đ”ĐœĐžĐ” ŃƒŃ€ĐŸĐČĐœŃ ЛПС-бДлĐșĐ°, ŃƒŃ€ĐŸĐČĐœŃ Đ˜Đ€Đ-Îł Đž ĐœĐ”ĐŸĐżŃ‚Đ”Ń€ĐžĐœĐ° ĐČ ĐŸĐ±Ń€Đ°Đ·Ń†Đ°Ń… сыĐČĐŸŃ€ĐŸŃ‚ĐșĐž ĐșŃ€ĐŸĐČĐž ĐżŃ€ĐŸĐČĐŸĐŽĐžĐ»ĐžŃŃŒ ĐČ Đ»Đ°Đ±ĐŸŃ€Đ°Ń‚ĐŸŃ€ĐžŃŃ… СтаĐČŃ€ĐŸĐżĐŸĐ»ŃŒŃĐșĐŸĐłĐŸ ĐœĐ°ŃƒŃ‡ĐœĐŸ-ĐžŃŃĐ»Đ”ĐŽĐŸĐČĐ°Ń‚Đ”Đ»ŃŒŃĐșĐŸĐłĐŸ ĐżŃ€ĐŸŃ‚ĐžĐČĐŸŃ‡ŃƒĐŒĐœĐŸĐłĐŸ ĐžĐœŃŃ‚ĐžŃ‚ŃƒŃ‚Đ° Đ ĐŸŃĐżĐŸŃ‚Ń€Đ”Đ±ĐœĐ°ĐŽĐ·ĐŸŃ€Đ° Đ Đ”Đ·ŃƒĐ»ŃŒŃ‚Đ°Ń‚Ń‹: про ĐžŃŃĐ»Đ”ĐŽĐŸĐČĐ°ĐœĐžĐž ĐșŃ€ĐŸĐČĐž Đ±ĐŸĐ»ŃŒĐœŃ‹Ń… ĐŸŃŃ‚Ń€Ń‹ĐŒ Đ±Ń€ŃƒŃ†Đ”Đ»Đ»Đ”Đ·ĐŸĐŒ ĐŽĐŸ Đž ĐżĐŸŃĐ»Đ” Đ»Đ”Ń‡Đ”ĐœĐžŃ ĐŸĐżŃ€Đ”ĐŽĐ”Đ»Đ”ĐœŃ‹ ĐżĐŸĐșазатДлО ĐœĐ”ĐŸĐżŃ‚Đ”Ń€ĐžĐœĐ°, Đ»ĐžĐżĐŸĐżĐŸĐ»ĐžŃĐ°Ń…Đ°Ń€ĐžĐŽ-сĐČŃĐ·Ń‹ĐČĐ°ŃŽŃ‰Đ”ĐłĐŸ бДлĐșĐ° Đž ĐžĐœŃ‚Đ”Ń€Ń„Đ”Ń€ĐŸĐœĐ°- Îł, Đ·ĐœĐ°Ń‡ĐžŃ‚Đ”Đ»ŃŒĐœĐŸ прДĐČŃ‹ŃˆĐ°ŃŽŃ‰ĐžĐ” ĐœĐŸŃ€ĐŒĐ°Đ»ŃŒĐœŃ‹Đ” Đ·ĐœĐ°Ń‡Đ”ĐœĐžŃ. ĐŸĐŸĐ»ŃƒŃ‡Đ”ĐœĐœŃ‹Đ” Ń€Đ”Đ·ŃƒĐ»ŃŒŃ‚Đ°Ń‚Ń‹ сĐČĐžĐŽĐ”Ń‚Đ”Đ»ŃŒŃŃ‚ĐČуют ĐŸ ŃĐŸŃ…Ń€Đ°ĐœŃŃŽŃ‰Đ”ĐŒŃŃ Đ°ĐșтоĐČĐœĐŸĐŒ ĐČĐŸŃĐżĐ°Đ»Đ”ĐœĐžĐž Đž Ń„ĐŸŃ€ĐŒĐžŃ€ĐŸĐČĐ°ĐœĐžĐž Ń…Ń€ĐŸĐœĐžŃ‡Đ”ŃĐșĐŸĐłĐŸ Đ±Ń€ŃƒŃ†Đ”Đ»Đ»Đ”Đ·Đ°. ЗаĐșĐ»ŃŽŃ‡Đ”ĐœĐžĐ”: ĐżĐ°Ń‚ĐŸĐłĐ”ĐœĐ”Ń‚ĐžŃ‡Đ”ŃĐșĐŸĐč ĐŸŃĐœĐŸĐČĐŸĐč праĐșтОчДсĐșĐž Đ·Đ°ĐșĐŸĐœĐŸĐŒĐ”Ń€ĐœĐŸĐč Ń‚Ń€Đ°ĐœŃŃ„ĐŸŃ€ĐŒĐ°Ń†ĐžĐž ĐŸŃŃ‚Ń€ĐŸĐč стаЮоо ĐžĐœŃ„Đ”Đșцоо ĐČ Ń…Ń€ĐŸĐœĐžŃ‡Đ”ŃĐșую яĐČĐ»ŃĐ”Ń‚ŃŃ ĐœĐ”ŃĐŸŃŃ‚ĐŸŃŃ‚Đ”Đ»ŃŒĐœĐŸŃŃ‚ŃŒ ĐČŃ€ĐŸĐ¶ĐŽĐ”ĐœĐœĐŸĐłĐŸ Đž аЮаптоĐČĐœĐŸĐłĐŸ ĐžĐŒĐŒŃƒĐœĐžŃ‚Đ”Ń‚Đ° ĐČ ĐŸŃ‚ĐœĐŸŃˆĐ”ĐœĐžĐž Đ±Ń€ŃƒŃ†Đ”Đ»Đ» с ŃĐŸĐ·ĐŽĐ°ĐœĐžĐ”ĐŒ ŃƒŃĐ»ĐŸĐČĐžĐč ĐŽĐ»Ń ĐœĐ”Đ·Đ°ĐČĐ”Ń€ŃˆĐ”ĐœĐœĐŸĐłĐŸ Ń„Đ°ĐłĐŸŃ†ĐžŃ‚ĐŸĐ·Đ° Đž ĐŽĐŸĐ»ĐłĐŸŃŃ€ĐŸŃ‡ĐœĐŸĐłĐŸ ĐČĐœŃƒŃ‚Ń€ĐžĐșĐ»Đ”Ń‚ĐŸŃ‡ĐœĐŸĐłĐŸ ĐżĐ°Ń€Đ°Đ·ĐžŃ‚ĐžŃ€ĐŸĐČĐ°ĐœĐžŃ. Đ˜Đ€Đ- Îł, ĐœĐ”ĐŸĐżŃ‚Đ”Ń€ĐžĐœ Đž ЛПС-Đ±Đ”Đ»ĐŸĐș ĐŸŃ‚ĐœĐŸŃŃŃ‚ŃŃ Đș ĐžĐŒĐŒŃƒĐœĐŸĐŒĐŸĐŽŃƒĐ»ĐžŃ€ŃƒŃŽŃ‰ĐžĐŒ фаĐșŃ‚ĐŸŃ€Đ°ĐŒ рДаĐșцоо ĐžĐŒĐŒŃƒĐœĐžŃ‚Đ”Ń‚Đ° ĐœĐ° ĐČĐŸĐ·Đ±ŃƒĐŽĐžŃ‚Đ”Đ»Ń, Đž ĐŸĐżŃ€Đ”ĐŽĐ”Đ»Đ”ĐœĐžĐ” ох ŃƒŃ€ĐŸĐČĐœŃ ĐČ ĐșŃ€ĐŸĐČĐž Đ±ĐŸĐ»ŃŒĐœŃ‹Ń… Đ±Ń€ŃƒŃ†Đ”Đ»Đ»Đ”Đ·ĐŸĐŒ ĐČĐŸĐ·ĐŒĐŸĐ¶ĐœĐŸ ĐžŃĐżĐŸĐ»ŃŒĐ·ĐŸĐČать ĐČ ĐșачДстĐČĐ” ĐŒĐ°Ń€ĐșĐ”Ń€ĐŸĐČ ĐČĐŸŃĐżĐ°Đ»Đ”ĐœĐžŃ Đž ĐČ ĐŒĐŸĐœĐžŃ‚ĐŸŃ€ĐžĐœĐłĐ” ŃŃ„Ń„Đ”ĐșтоĐČĐœĐŸŃŃ‚Đž Đ°ĐœŃ‚ĐžĐ±Đ°ĐșŃ‚Đ”Ń€ĐžĐ°Đ»ŃŒĐœĐŸĐč тДрапОО

    Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Get PDF

    Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Get PDF
    In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. For example, a key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process versus those that measure fl ux through the autophagy pathway (i.e., the complete process including the amount and rate of cargo sequestered and degraded). In particular, a block in macroautophagy that results in autophagosome accumulation must be differentiated from stimuli that increase autophagic activity, defi ned as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (inmost higher eukaryotes and some protists such as Dictyostelium ) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the fi eld understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. It is worth emphasizing here that lysosomal digestion is a stage of autophagy and evaluating its competence is a crucial part of the evaluation of autophagic flux, or complete autophagy. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. Along these lines, because of the potential for pleiotropic effects due to blocking autophagy through genetic manipulation it is imperative to delete or knock down more than one autophagy-related gene. In addition, some individual Atg proteins, or groups of proteins, are involved in other cellular pathways so not all Atg proteins can be used as a specific marker for an autophagic process. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular autophagy assays, we hope to encourage technical innovation in the field

    Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

    Get PDF
    In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field
    • 

    corecore